Glynase



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 40.0%
Type 2 Diabetes Mellitus 20.0%
Hypertension 10.0%
Arthropathy 6.7%
Blood Cholesterol Increased 6.7%
Anxiety 3.3%
Cardiac Disorder 3.3%
Chest Pain 3.3%
Glaucoma 3.3%
Medical Diet 3.3%
Drug Ineffective 15.8%
Blood Glucose Abnormal 10.5%
Muscle Spasms 10.5%
Blood Glucose Increased 5.3%
Cardiac Disorder 5.3%
Gastric Disorder 5.3%
Glaucoma 5.3%
Malaise 5.3%
Neoplasm Malignant 5.3%
No Adverse Event 5.3%
Pain In Extremity 5.3%
Pneumonia 5.3%
Rash 5.3%
Urticaria 5.3%
Weight Decreased 5.3%
Secondary
Type 2 Diabetes Mellitus 46.2%
Diabetes Mellitus 38.5%
Chest Pain 3.8%
High Density Lipoprotein Decreased 3.8%
Rash 3.8%
Renal Cell Carcinoma Stage Unspecified 3.8%
Muscle Spasms 21.1%
Death 15.8%
Rash 10.5%
Dyspnoea 5.3%
Gastrointestinal Disorder 5.3%
Haemorrhagic Stroke 5.3%
Nasopharyngitis 5.3%
Prostate Cancer 5.3%
Treatment Noncompliance 5.3%
Unevaluable Event 5.3%
Urticaria 5.3%
Weight Decreased 5.3%
Wrong Technique In Drug Usage Process 5.3%
Concomitant
Diabetes Mellitus 16.8%
Diabetes Mellitus Non-insulin-dependent 16.3%
Drug Use For Unknown Indication 16.0%
Type 2 Diabetes Mellitus 13.0%
Product Used For Unknown Indication 8.0%
Hypertension 4.3%
Blood Cholesterol Increased 3.5%
Menopause 3.0%
Arrhythmia 2.5%
Arthritis 2.5%
Coronary Artery Bypass 2.0%
Bladder Cancer 1.8%
Cerebrovascular Accident 1.5%
Chronic Obstructive Pulmonary Disease 1.5%
Myelodysplastic Syndrome 1.5%
Osteoarthritis 1.5%
Osteoporosis 1.3%
Prophylaxis 1.3%
Cough 1.0%
Myalgia 1.0%
Weight Decreased 20.1%
Myocardial Infarction 12.5%
Vomiting 11.1%
Blood Glucose Increased 8.3%
Nausea 6.9%
Weight Increased 6.3%
Urinary Tract Infection 4.9%
Coronary Artery Disease 3.5%
Tremor 3.5%
Sleep Apnoea Syndrome 2.8%
Amnesia 2.1%
Cardiovascular Disorder 2.1%
Cerebrovascular Accident 2.1%
Hypoglycaemia 2.1%
Joint Swelling 2.1%
Pain 2.1%
Transient Ischaemic Attack 2.1%
Type 2 Diabetes Mellitus 2.1%
White Blood Cell Count Increased 2.1%
Atrioventricular Block 1.4%